Litcius/Paper detail

Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial

Naveed Sattar, Ian J. Neeland, Olof Dahlqvist Leinhard, Laura Fernández Landó, Ross Bray, Jennifer Linge, Ángel Rodríguez

2025The Lancet Diabetes & Endocrinology75 citationsDOIOpen Access PDF

Topics & Concepts

MedicineType 2 diabetesPost-hoc analysisOpen labelPost hocGroup (periodic table)Diabetes mellitusRandomized controlled trialPhysical therapyPhysical medicine and rehabilitationInternal medicineEndocrinologyOrganic chemistryChemistryNutrition and Health in AgingBody Composition Measurement TechniquesCardiovascular Function and Risk Factors
Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial | Litcius